MAD Study Evaluating the Safety, Tolerability, and Pharmacokinetic Effects of N91115 in Healthy Subjects

NCT02013388 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

49

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: N91115
DRUG: Placebo
DRUG: N91115
DRUG: Placebo-Day 1 only

Sponsor

Nivalis Therapeutics, Inc.